Glial cell line-derived neurotrophic factor (GDNF) receptor alpha-1 (GFR alpha 1) is highly selective for GDNF versus artemin.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 15709767)

Published in Biochemistry on February 22, 2005

Authors

Paul Carmillo1, Lone Dagø, Eric S Day, Dane S Worley, Anthony Rossomando, Lee Walus, Olivia Orozco, Carolyn Buckley, Stephan Miller, Albert Tse, Richard L Cate, Carl Rosenblad, Dinah W Y Sah, Mette Grønborg, Adrian Whitty

Author Affiliations

1: Biogen Idec, Inc., 14 Cambridge Center, Cambridge, Massachusetts 02142, USA.

Articles by these authors

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol (2008) 6.81

Rational design of cationic lipids for siRNA delivery. Nat Biotechnol (2010) 4.97

RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol (2006) 4.38

Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A (2010) 4.25

The resurgence of covalent drugs. Nat Rev Drug Discov (2011) 4.09

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev (2010) 3.99

Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med (2013) 3.97

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther (2010) 3.26

LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci (2004) 3.24

Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci (2002) 3.12

First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov (2013) 2.88

Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci (2004) 2.29

Multiple actions of systemic artemin in experimental neuropathy. Nat Med (2003) 2.12

Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination. Nat Med (2011) 2.08

The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc Natl Acad Sci U S A (2003) 2.07

Structural conservation of druggable hot spots in protein-protein interfaces. Proc Natl Acad Sci U S A (2011) 1.95

Small-molecule inhibition of TNF-alpha. Science (2005) 1.83

Quantitative analysis of the activation mechanism of the multicomponent growth-factor receptor Ret. Nat Chem Biol (2006) 1.68

Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design. Protein Sci (2006) 1.55

Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study. J Travel Med (2014) 1.49

Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc Imaging (2009) 1.49

Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury. Nat Neurosci (2008) 1.47

The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions. Curr Opin Chem Biol (2009) 1.46

Simultaneous adrenal and extra-adrenal myelolipoma - an uncommon incident: case report and review of the literature. World J Surg Oncol (2008) 1.46

N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model. Bioconjug Chem (2006) 1.33

Catheter ablation of atrial fibrillation using the Navx-/Ensite-system and a CT-/MRI-guided approach. Clin Res Cardiol (2009) 1.31

Current concepts in the classification, diagnosis and treatment of vascular anomalies. Eur J Radiol (2010) 1.30

Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest (2003) 1.27

Targeting the Nogo receptor to treat central nervous system injuries. Nat Rev Drug Discov (2003) 1.25

Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry (2005) 1.23

Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene (2005) 1.22

Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. J Biol Chem (2003) 1.17

siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells. Hum Mol Genet (2008) 1.15

Multislice first-pass myocardial perfusion imaging: Comparison of saturation recovery (SR)-TrueFISP-two-dimensional (2D) and SR-TurboFLASH-2D pulse sequences. J Magn Reson Imaging (2004) 1.14

Perfusion MR imaging with FAIR true FISP spin labeling in patients with and without renal artery stenosis: initial experience. Radiology (2006) 1.11

Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J Interferon Cytokine Res (2002) 1.11

Quantitative proteomics and protein network analysis of hippocampal synapses of CaMKIIalpha mutant mice. J Proteome Res (2007) 1.10

Assessment of left ventricular myocardial function using 16-slice multidetector-row computed tomography: comparison with magnetic resonance imaging and echocardiography. Eur Radiol (2005) 1.07

A comprehensive approach to the analysis of contrast enhanced cardiac MR images. IEEE Trans Med Imaging (2008) 1.06

Development of an Fn14 agonistic antibody as an anti-tumor agent. MAbs (2011) 1.04

Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration. J Pharmacol Exp Ther (2011) 1.02

Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis. Protein Sci (2010) 1.02

Artemin crystal structure reveals insights into heparan sulfate binding. Biochemistry (2006) 1.01

Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla. Invest Radiol (2006) 1.00

Widespread suppression of huntingtin with convection-enhanced delivery of siRNA. Exp Neurol (2011) 1.00

Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology--initial clinical results. Radiology (2005) 0.99

Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor). Biochemistry (2006) 0.99

Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. Eur J Neurosci (2005) 0.98

Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology. Anal Biochem (2004) 0.98

Direct CNS delivery of siRNA mediates robust silencing in oligodendrocytes. Oligonucleotides (2009) 0.97

Magnetic resonance elastography of the breast: correlation of signal intensity data with viscoelastic properties. Invest Radiol (2005) 0.97

Novel therapeutic modalities to address nondrugable protein interaction targets. Neuropsychopharmacology (2008) 0.97

siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic Stimuli. Cancer Ther (2008) 0.96

Relationship between hot spot residues and ligand binding hot spots in protein-protein interfaces. J Chem Inf Model (2012) 0.95

Quantification and modeling of tripartite CD2-, CD58FC chimera (alefacept)-, and CD16-mediated cell adhesion. J Biol Chem (2007) 0.94

Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial. Obesity (Silver Spring) (2010) 0.93

Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector. Neuroreport (2002) 0.93

Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters. Protein Expr Purif (2004) 0.93

Three-dimensional morphological magnetic resonance imaging in infants and children with congenital heart disease. Pediatr Radiol (2006) 0.92

Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta. Mol Endocrinol (2010) 0.92

Ultrafast whole-body MR angiography with two-dimensional parallel imaging at 3.0 T: feasibility study. Radiology (2008) 0.92

Scimitar syndrome: morphological diagnosis and assessment of hemodynamic significance by magnetic resonance imaging. Eur Radiol (2003) 0.92

Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1. Biochemistry (2002) 0.92

Juvenile and adult congenital heart disease: time-resolved 3D contrast-enhanced MR angiography. Radiology (2007) 0.91

Induction of dopaminergic neurons from growth factor expanded neural stem/progenitor cell cultures derived from human first trimester forebrain. Brain Res Bull (2006) 0.91

Assessment of left ventricular volumes and mass with fast 3D cine steady-state free precession k-t space broad-use linear acquisition speed-up technique (k-t BLAST). J Magn Reson Imaging (2008) 0.91

Comprehensive experimental and computational analysis of binding energy hot spots at the NF-κB essential modulator/IKKβ protein-protein interface. J Am Chem Soc (2013) 0.91

New approaches for the treatment of pain: the GDNF family of neurotrophic growth factors. Curr Top Med Chem (2005) 0.91

A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelin. J Biol Chem (2004) 0.90

Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism. ACS Chem Biol (2011) 0.90

IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice. Brain Res (2009) 0.89

Lipophilic siRNAs mediate efficient gene silencing in oligodendrocytes with direct CNS delivery. J Control Release (2010) 0.89

Distribution of GDNF family receptor alpha3 and RET in rat and human non-neural tissues. J Mol Histol (2006) 0.88

Comparison of binding characteristics and in vitro activities of three inhibitors of vascular endothelial growth factor A. Mol Pharm (2014) 0.88

Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation. Exp Neurol (2007) 0.88

Understanding cytokine and growth factor receptor activation mechanisms. Crit Rev Biochem Mol Biol (2012) 0.88

Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries. Radiology (2010) 0.88

Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport. Hum Mol Genet (2009) 0.88

Adenosine stress cardiac magnetic resonance imaging for the assessment of ischemic heart disease. Clin Res Cardiol (2008) 0.88

Detection of regional myocardial perfusion deficit using rest and stress perfusion MRI: a feasibility study. AJR Am J Roentgenol (2005) 0.87

Stoichiometry of LTbetaR binding to LIGHT. Biochemistry (2006) 0.87

Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Mol Endocrinol (2003) 0.87

Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Exp Neurol (2005) 0.87

Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches. MAbs (2013) 0.86

Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore. Anal Biochem (2013) 0.86

CRIPTO3, a presumed pseudogene, is expressed in cancer. Biochem Biophys Res Commun (2008) 0.86

Renal magnetic resonance angiography at 3.0 Tesla using a 32-element phased-array coil system and parallel imaging in 2 directions. Invest Radiol (2006) 0.85